• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci.与其他六种药物相比,头孢噻肟对12株青霉素敏感和耐药肺炎球菌的抗生素后效应。
Antimicrob Agents Chemother. 1997 Oct;41(10):2173-6. doi: 10.1128/AAC.41.10.2173.
2
MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents.将GV 118819X(三苯菌素)与其他药物的抗肺炎球菌活性进行的最低抑菌浓度(MIC)和杀菌动力学研究。
Antimicrob Agents Chemother. 1997 Jan;41(1):148-55. doi: 10.1128/AAC.41.1.148.
3
Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.左氧氟沙星和环丙沙星对金黄色葡萄球菌和肺炎链球菌的抗生素后效应及抗生素后亚抑菌浓度效应比较
Antimicrob Agents Chemother. 1997 May;41(5):950-5. doi: 10.1128/AAC.41.5.950.
4
Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents.厄他培南(MK-0826)与其他药物相比的抗肺炎球菌活性。
Antimicrob Agents Chemother. 2002 Jan;46(1):42-6. doi: 10.1128/AAC.46.1.42-46.2002.
5
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.左氧氟沙星与氧氟沙星、环丙沙星、红霉素、阿奇霉素及克拉霉素相比,对20株肺炎球菌的抗生素后效应及抗生素后亚抑菌浓度效应
Antimicrob Agents Chemother. 1998 May;42(5):1253-5. doi: 10.1128/AAC.42.5.1253.
6
Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.青霉素G与六种大环内酯类药物对肺炎链球菌的杀菌活性、抗生素后效应及细菌毒力影响的比较研究
Antimicrob Agents Chemother. 1997 Apr;41(4):781-4. doi: 10.1128/AAC.41.4.781.
7
Postantibiotic and sub-MIC effects of benzylpenicillin against Streptococcus pneumoniae with different susceptibilities for penicillin.苄青霉素对不同青霉素敏感性的肺炎链球菌的抗生素后效应及亚抑菌浓度效应
Chemotherapy. 2003 Dec;49(6):287-93. doi: 10.1159/000074528.
8
Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.九种口服制剂对社区获得性感染中革兰氏阳性菌和革兰氏阴性菌的活性:在β-内酰胺类和大环内酯类抗菌药物的比较评估中使用药代动力学/药效学断点
Clin Ther. 2003 Jan;25(1):169-77. doi: 10.1016/s0149-2918(03)90021-x.
9
In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem.90株对青霉素敏感及耐药的肺炎球菌对青霉素G、阿莫西林、阿莫西林/克拉维酸、头孢克洛、头孢呋辛、头孢泊肟、头孢克肟和亚胺培南的体外敏感性。
Folia Microbiol (Praha). 1998;43(1):68-70. doi: 10.1007/BF02815546.
10
Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.将青霉素敏感及耐药、红霉素敏感及耐药的肺炎球菌对新型酮内酯类药物HMR 3647(RU 66647)的敏感性与对其他17种药物的敏感性进行比较。
Antimicrob Agents Chemother. 1998 Mar;42(3):624-30. doi: 10.1128/AAC.42.3.624.

引用本文的文献

1
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis.Sanfetrinem,一种重新用于治疗结核病的口服β-内酰胺抗生素。
Drug Resist Updat. 2025 May;80:101213. doi: 10.1016/j.drup.2025.101213. Epub 2025 Feb 15.
2
Characterization of sulopenem antimicrobial activity using time-kill kinetics, synergy, post-antibiotic effect, and sub-inhibitory MIC effect methods against and isolates.使用时间杀菌动力学、协同作用、抗生素后效应和亚抑菌MIC效应方法对[具体菌种]分离株进行舒洛培南抗菌活性的表征。
Microbiol Spectr. 2025 Mar 4;13(3):e0189824. doi: 10.1128/spectrum.01898-24. Epub 2025 Feb 5.
3
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis.Sanfetrinem,一种经重新用途开发用于治疗结核病的口服β-内酰胺抗生素。
bioRxiv. 2024 Oct 10:2024.10.10.617558. doi: 10.1101/2024.10.10.617558.
4
Bioequivalence evaluation of two capsule formulations of amoxicillin in healthy adult male bangladeshi volunteers: A single-dose, randomized, open-label, two-period crossover study.两种阿莫西林胶囊制剂在健康成年孟加拉国男性志愿者中的生物等效性评价:一项单剂量、随机、开放标签、两期交叉研究。
Curr Ther Res Clin Exp. 2008 Dec;69(6):504-13. doi: 10.1016/S0011-393X(09)00002-2.
5
Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections.新型口服头孢菌素的药代动力学和药效学:对社区获得性下呼吸道感染治疗的影响。
Clin Drug Investig. 1998;16(4):335-46. doi: 10.2165/00044011-199816040-00008.
6
Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.头孢曲松:其在社区获得性感染和医院感染管理中应用的最新情况
Drugs. 2002;62(7):1041-89. doi: 10.2165/00003495-200262070-00005.
7
Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents.传染病的新兴策略:新型碳青霉烯类和三联抗菌剂
Drugs. 2001;61(5):553-64. doi: 10.2165/00003495-200161050-00001.
8
Antipneumococcal activity of ABT-773 compared to those of 10 other agents.ABT-773与其他10种药物的抗肺炎球菌活性比较。
Antimicrob Agents Chemother. 2000 Jul;44(7):1894-9. doi: 10.1128/AAC.44.7.1894-1899.2000.
9
Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.与其他11种药物相比,吉米沙星对流感嗜血杆菌和卡他莫拉菌的活性及抗生素后效应。
Antimicrob Agents Chemother. 2000 Mar;44(3):633-9. doi: 10.1128/AAC.44.3.633-639.2000.
10
Antipneumococcal activities of gemifloxacin compared to those of nine other agents.吉米沙星与其他九种药物的抗肺炎球菌活性比较。
Antimicrob Agents Chemother. 2000 Feb;44(2):304-10. doi: 10.1128/AAC.44.2.304-310.2000.

本文引用的文献

1
MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents.将GV 118819X(三苯菌素)与其他药物的抗肺炎球菌活性进行的最低抑菌浓度(MIC)和杀菌动力学研究。
Antimicrob Agents Chemother. 1997 Jan;41(1):148-55. doi: 10.1128/AAC.41.1.148.
2
Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.1994年至1995年冬季美国门诊患者中分离出的肺炎链球菌的耐药性:一项30中心全国监测研究的结果
Antimicrob Agents Chemother. 1996 May;40(5):1208-13. doi: 10.1128/AAC.40.5.1208.
3
Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management.急性中耳炎中耐青霉素肺炎链球菌:危险因素、药敏模式及抗菌治疗
Pediatr Infect Dis J. 1995 Sep;14(9):751-9. doi: 10.1097/00006454-199509000-00005.
4
Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829.170株青霉素敏感和耐药肺炎球菌对六种口服头孢菌素、四种喹诺酮类药物、去乙酰头孢噻肟、Ro 23 - 9424和RP 67829的敏感性
J Antimicrob Chemother. 1993 Feb;31(2):273-80. doi: 10.1093/jac/31.2.273.
5
Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem.美罗培南的抗生素后效应及抗生素后亚抑菌浓度效应研究。
J Antimicrob Chemother. 1993 Jun;31(6):881-92. doi: 10.1093/jac/31.6.881.
6
Emergence of drug-resistant pneumococcal infections in the United States.美国耐药肺炎球菌感染的出现。
JAMA. 1994 Jun 15;271(23):1831-5.
7
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.耐抗生素肺炎链球菌所致感染的管理
N Engl J Med. 1994 Aug 11;331(6):377-82. doi: 10.1056/NEJM199408113310607.
8
Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment.口服抗生素对耐青霉素肺炎链球菌引起的中耳和鼻窦感染的活性:对治疗的启示
Pediatr Infect Dis J. 1994 Jul;13(7):585-9. doi: 10.1097/00006454-199407000-00001.
9
In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.1992年和1993年12种口服抗菌药物对来自美国医疗中心的四种细菌性呼吸道病原体的体外活性。
Antimicrob Agents Chemother. 1994 Oct;38(10):2419-25. doi: 10.1128/AAC.38.10.2419.
10
In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria.三抗菌GV104326对革兰氏阳性菌、革兰氏阴性菌和厌氧菌的体外活性。
Antimicrob Agents Chemother. 1994 Oct;38(10):2362-8. doi: 10.1128/AAC.38.10.2362.

与其他六种药物相比,头孢噻肟对12株青霉素敏感和耐药肺炎球菌的抗生素后效应。

Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci.

作者信息

Spangler S K, Lin G, Jacobs M R, Appelbaum P C

机构信息

Department of Pathology, Hershey Medical Center, Pennsylvania 17033, USA.

出版信息

Antimicrob Agents Chemother. 1997 Oct;41(10):2173-6. doi: 10.1128/AAC.41.10.2173.

DOI:10.1128/AAC.41.10.2173
PMID:9333043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC164088/
Abstract

The postantibiotic effect (PAE) and postantibiotic sub-MIC effect (PAE-SME) of sanfetrinem were compared to those of penicillin G, amoxicillin, cefpodoxime, ceftriaxone, imipenem, and clarithromycin against four penicillin-susceptible, four intermediately susceptible, and four resistant pneumococci. The MICs of imipenem were the lowest against all of the strains (0.03 to 0.5 microg/ml), followed by those of sanfetrinem (0.016 to 1.0 microg/ml), amoxicillin and ceftriaxone (0.016 to 2.0 microg/ml), and cefpodoxime (0.03 to 8.0 microg/ml). High-level resistance to clarithromycin (MIC, >64.0 microg/ml) was seen in three selected strains. The PAEs of all of the oral beta-lactams tested were similar for all of the strains, ranging from 1 to 6.5 h. The PAEs of ceftriaxone and imipenem ranged from 1 to 8 h, and those of clarithromycin ranged from 1 to 7 h. The mean PAEs of all of the beta-lactams and clarithromycin were 2.8 to 4.3 and 2.5 h, respectively. PAE-SMEs could not be determined for all of the strains due to complete killing, especially at high subinhibitory concentrations. However, the overall pattern with all of the compounds tested was that PAE-SMEs were longer than PAEs. Measurable PAE-SMEs of sanfetrinem at the three subinhibitory concentrations (0.125, 0.25, and 0.5 times the MIC) were 2 to 7, 2 to 7, and 3 to 6 h, while those of amoxicillin and cefpodoxime were 1 to 7.5, 2 to 4, and 4 to 9 and 2 to 7, 4 to 7, and 4 to 6 h, respectively. Measurable PAE-SMEs of ceftriaxone and imipenem were 1 to 6.5, 2 to 9, and 2 to 9 and 1.5 to 6, 2 to 5.8, and 4 to 7.7 h, respectively. Measurable clarithromycin PAE-SMEs were 1 to 5, 1 to 5, and 1 to 6 h at the three concentrations.

摘要

将三氟沙星的抗生素后效应(PAE)和抗生素后亚抑菌浓度效应(PAE-SME)与青霉素G、阿莫西林、头孢泊肟、头孢曲松、亚胺培南及克拉霉素针对4株青霉素敏感、4株中度敏感及4株耐药肺炎球菌的效应进行了比较。亚胺培南对所有菌株的最低抑菌浓度(MIC)最低(0.03至0.5μg/ml),其次是三氟沙星(0.016至1.0μg/ml)、阿莫西林和头孢曲松(0.016至2.0μg/ml)以及头孢泊肟(0.03至8.0μg/ml)。在3株选定菌株中观察到对克拉霉素的高水平耐药(MIC,>64.0μg/ml)。所有受试口服β-内酰胺类药物对所有菌株的PAE相似,范围为1至6.5小时。头孢曲松和亚胺培南的PAE范围为1至8小时,克拉霉素的PAE范围为1至7小时。所有β-内酰胺类药物和克拉霉素的平均PAE分别为2.8至4.3小时和2.5小时。由于完全杀菌,尤其是在高亚抑菌浓度时,并非所有菌株都能测定PAE-SME。然而,所有受试化合物的总体模式是PAE-SME长于PAE。三氟沙星在3个亚抑菌浓度(0.125、0.25和0.5倍MIC)下可测量的PAE-SME分别为2至7小时、2至7小时和3至6小时,而阿莫西林和头孢泊肟的PAE-SME分别为1至7.5小时、2至4小时和4至9小时以及2至7小时、4至7小时和4至6小时。头孢曲松和亚胺培南可测量的PAE-SME分别为1至6.5小时、2至9小时和2至9小时以及1.5至6小时、2至5.8小时和4至7.7小时。克拉霉素在3个浓度下可测量到的PAE-SME分别为1至5小时、1至5小时和1至6小时。